These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The kidney and hypertension]. Scholze J; Rautenberg B Z Arztl Fortbild (Jena); 1994 Jan; 88(1):31-6. PubMed ID: 8154137 [No Abstract] [Full Text] [Related]
5. Pediatric post-transplant hypertension: a review of current standards of care. Ingelfinger JA; Brewer ED Child Nephrol Urol; 1992; 12(2-3):139-46. PubMed ID: 1628272 [No Abstract] [Full Text] [Related]
6. Management of hypertensive emergencies. Singhi SC; Kohli V Indian Pediatr; 1992 Sep; 29(9):1181-6. PubMed ID: 1452325 [No Abstract] [Full Text] [Related]
7. [A familial history of hypertension is associated with the development of hypertension and nephroangiosclerosis in patients with glomerulonephritis caused by mesangial IgA deposits]. Boulahrouz R; Autuly V; Charasse C; Le Cacheux P; Ang KS; Ramee MP; Simon P Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1065-8. PubMed ID: 8949380 [TBL] [Abstract][Full Text] [Related]
8. Hypertension after renal transplantation: cyclosporine increases the diagnostic and therapeutic considerations. Curtis JJ Am J Kidney Dis; 1989 Jun; 13(6 Suppl 1):28-32. PubMed ID: 2660549 [No Abstract] [Full Text] [Related]
9. [Hypertension in diabetes mellitus. Causes, follow-up and treatment]. Klaus D Med Klin (Munich); 1994 Jun; 89(6):330-8. PubMed ID: 8072457 [No Abstract] [Full Text] [Related]
10. Renal and endocrine hypertension. A review. Chan JC Int J Pediatr Nephrol; 1983 Sep; 4(3):187-96. PubMed ID: 6358076 [TBL] [Abstract][Full Text] [Related]
11. Accelerated hypertension and nephroangiosclerosis associated with antiphospholipid syndrome. Report of two cases and review of the literature. Durand JM; Lefevre P; Kaplanski G; Casanova P; Soubeyrand J Clin Rheumatol; 1994 Dec; 13(4):635-40. PubMed ID: 7697970 [TBL] [Abstract][Full Text] [Related]
12. Is nephroangiosclerosis a hypertension-induced nephropathy? Zuccalà A; Zucchelli P Contrib Nephrol; 1996; 119():110-4. PubMed ID: 8783600 [No Abstract] [Full Text] [Related]
13. Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension. Mimran A J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S45-50. PubMed ID: 1382165 [TBL] [Abstract][Full Text] [Related]
14. [Renal sequelae of sympathetic hyperactivity]. Watschinger B; Habicht A Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546 [No Abstract] [Full Text] [Related]
16. [Antihypertensive treatment in kidney diseases: whom, with what, how intensively?]. Ritz E; Heidland A; Nowack R; Rambausek M Dtsch Med Wochenschr; 1990 Aug; 115(35):1325-8. PubMed ID: 2202580 [No Abstract] [Full Text] [Related]
17. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy. Innes A; Johnston PA; Morgan AG; Davison AM; Burden RP Q J Med; 1993 Apr; 86(4):271-5. PubMed ID: 8327642 [TBL] [Abstract][Full Text] [Related]
18. [Effect of hypotensive therapy on kidney function in hypertensive states]. Shershnev VG; Shcherban' NN; Gorodetskiĭ AL Ter Arkh; 1973 Oct; 45(10):85-8. PubMed ID: 4783250 [No Abstract] [Full Text] [Related]
19. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs. Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815 [TBL] [Abstract][Full Text] [Related]
20. 1995 update of the working group reports on chronic renal failure and renovascular hypertension. National High Blood Pressure Education Program Working Group. Arch Intern Med; 1996 Sep; 156(17):1938-47. PubMed ID: 8823147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]